Publications by authors named "K Marty"
Background: The Canadian National Vaccine Safety Network conducted active safety surveillance for COVID-19 vaccines. This study aimed to characterize the short-to-medium term safety of mRNA COVID-19 vaccines across the pediatric age spectrum.
Methods: In this cohort study, vaccinated and unvaccinated children and adolescents aged 6 months to 19 years from eight Canadian provinces and territories were invited to participate.
Introduction: The Canadian National Vaccine Safety Network (CANVAS) conducted active participant-based surveillance for adverse events following immunization during the COVID-19 vaccine campaign. This study evaluated the association between COVID-19 vaccination and neurological adverse events.
Methods: Participants were invited to complete online surveys to report health events that prevented daily activities and/or required medical attention within 7 days after COVID-19 vaccination or 7 days prior to the survey (unvaccinated controls); follow-up surveys were sent 7 months later.
Background: The Canadian National Vaccine Safety (CANVAS) network conducted a multi-center, prospective vaccine safety study to collect safety data after dose 1 and 2 of COVID-19 vaccines and follow up safety information 7 months after dose 1.
Objective: This study aimed to describe and evaluate the recruitment methods used by CANVAS and the retention of participants by each modality.
Methods: CANVAS deployed a multi-pronged recruitment approach to reach a larger sample, without in-person recruitment.
Article Synopsis
- This study analyzed the safety of COVID-19 vaccines in adults aged 65 and older using data from the Canadian National Vaccine Safety Network, focusing on both vaccinated and unvaccinated individuals across seven regions.
- Researchers assessed health events that occurred within 7 days of vaccination and 7 months after the first dose, concluding that serious health events were infrequent (≤0.3%) and not higher than in unvaccinated adults.
- The findings support the safety of mRNA COVID-19 vaccines, suggesting they are safe for older adults and can provide reassurance for vaccination efforts in this age group.
Oncology nurses need an understanding of genomic science to provide optimal care, yet they may have limited background in how this science guides treatment. The Oncology Nursing Society (ONS) responded to this identified need.
View Article and Find Full Text PDF